Microglial IKKβ Inhibition to Block NF-κB-Mediated Inflammation
🧪 Overview
Chronic glial NF-κB activation drives cytokine-mediated dopaminergic toxicity. IKKβ inhibition theoretically reduces neuroinflammation but faces severe safety liabilities (immunosuppression, malignancy risk) and complete absence of human validation, compounded by failed NF-κB-targeting trials in ALS/MS.
🧬 Mechanism
⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — IKKΒ
No curated PDB or AlphaFold mapping for IKKΒ yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for IKKβ (CHUK).
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
▸Metadataorigin_type: debate_synthesizer
| origin_type | debate_synthesizer |
| target_gene | IKKβ (CHUK) |
| _schema_version | 1 |
| composite_score | 0.36 |